ClinVar Miner

Submissions for variant NM_000719.7(CACNA1C):c.5478G>A (p.Ala1826=)

gnomAD frequency: 0.00023  dbSNP: rs200283756
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001721097 SCV000223313 likely benign not provided 2019-04-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV000242415 SCV000319046 likely benign Cardiovascular phenotype 2016-06-06 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV000547992 SCV000627564 benign Long QT syndrome 2024-01-29 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001721097 SCV002048908 benign not provided 2022-02-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003398877 SCV004121852 benign not specified 2023-10-19 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001721097 SCV004132357 likely benign not provided 2023-01-01 criteria provided, single submitter clinical testing CACNA1C: BP4, BP7
Breakthrough Genomics, Breakthrough Genomics RCV001721097 SCV005213580 likely benign not provided criteria provided, single submitter not provided
PreventionGenetics, part of Exact Sciences RCV003965227 SCV004776628 likely benign CACNA1C-related disorder 2024-02-08 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.